quinoxalines has been researched along with Optic Atrophy, Hereditary, Leber in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatti, MT; Biousse, V; Chen, K; David, R; Farris, BK; Hamilton, SR; Keaney, RP; Lesser, RL; Newman, NJ; Newman, SA; Turbin, RE | 1 |
| Bhatti, MT; Biousse, V; Farris, BK; Hamilton, SR; Lesser, RL; Newman, NJ; Newman, SA; Turbin, RE | 1 |
2 trial(s) available for quinoxalines and Optic Atrophy, Hereditary, Leber
| Article | Year |
|---|---|
Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite.
Topics: Administration, Topical; Adolescent; Adrenergic alpha-Agonists; Adult; Brimonidine Tartrate; DNA, Mitochondrial; Female; Functional Laterality; Humans; Male; Middle Aged; Mutation; Optic Atrophy, Hereditary, Leber; Pilot Projects; Premedication; Prospective Studies; Quinoxalines; Treatment Outcome; Visual Acuity; Visual Fields | 2005 |
Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial.
Topics: Administration, Topical; Adolescent; Adrenergic alpha-Agonists; Adult; Brimonidine Tartrate; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Optic Atrophy, Hereditary, Leber; Pilot Projects; Prospective Studies; Quinoxalines; Vision Disorders; Visual Field Tests; Visual Fields | 2006 |